Trials / Terminated
TerminatedNCT02434549
Botulinum Toxin-A as a Treatment for Chronic Muscle-Related Pain in Adults With Spastic Cerebral Palsy: a Randomized Controlled Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Kristina Tedroff · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this double-blinded, placebo-controlled study is to test if treatment with Botulinum toxin-A is effective in reducing chronic muscle-related pain in adults with spastic cerebral palsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dysport® | Intramuscular injections in spastic muscle with regional muscle-related pain |
| DRUG | Normal saline | Intramuscular injections in spastic muscle with regional muscle-related pain |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2018-01-26
- Completion
- 2018-10-05
- First posted
- 2015-05-05
- Last updated
- 2018-10-09
Locations
2 sites across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02434549. Inclusion in this directory is not an endorsement.